French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan silent on reports foreign minister joined Philippines business trip
08/28/2025 11:36 AM - Society
Taiwan headline news
08/28/2025 10:40 AM - Business
Taiwan shares open lower
08/28/2025 09:12 AM - Society
Magnitude 6 earthquake rocks northeastern Taiwan
08/27/2025 09:38 PM - Society
3 TSMC employees indicted on trade secret theft charges
08/27/2025 09:33 PM